Search research articles
Contact Us
Filters
Showing results (51-60 of 85) with videos related to
Page
of 9
Sort By:
Oncology Reports
|
May 20, 2011
Current results of pelvic perfusion for non-resectable relapsing of pelvic cancer
M Santinami, F Cascinelli, A Chiti, et al.
AJNR. American Journal of Neuroradiology
|
April 13, 2013
A better characterization of spinal cord damage in multiple sclerosis: a diffusional kurtosis imaging study
E Raz, M Bester, E E Sigmund, et al.
Acta Neurologica Scandinavica
|
August 9, 2016
Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex<sup>®</sup>
A Carotenuto, R Iodice, M Petracca, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 17, 2011
Multiple Sclerosis Severity Scale and whole-brain N-acetylaspartate concentration for patients' assessment
D J Rigotti, A Gass, L Achtnichts, et al.
AJNR. American Journal of Neuroradiology
|
November 27, 2012
Cognitive impairment in mild traumatic brain injury: a longitudinal diffusional kurtosis and perfusion imaging study
E J Grossman, J H Jensen, J S Babb, et al.
AJNR. American Journal of Neuroradiology
|
September 26, 2007
Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging
Y Ge, J H Jensen, H Lu, et al.
Neurology
|
April 21, 2012
Two-year serial whole-brain N-acetyl-L-aspartate in patients with relapsing-remitting multiple sclerosis
D J Rigotti, M Inglese, I I Kirov, et al.
European Journal of Neurology
|
August 17, 2019
Preserved brain functional plasticity after upper limb task-oriented rehabilitation in progressive multiple sclerosis
G Boffa, A Tacchino, E Sbragia, et al.
Journal of Endocrinological Investigation
|
February 2, 2012
Vitamin D and parameters of calcium homeostasis in inpatients with and without Type 2 diabetes mellitus
V Carnevale, M Inglese, M A Annese, et al.
Journal of the Neurological Sciences
|
May 27, 2021
Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic?
F Tazza, C Lapucci, M Cellerino, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 85) with videos related to
Sort By:
Page
of 9
Oncology Reports
|
May 20, 2011
Current results of pelvic perfusion for non-resectable relapsing of pelvic cancer
M Santinami, F Cascinelli, A Chiti, et al.
AJNR. American Journal of Neuroradiology
|
April 13, 2013
A better characterization of spinal cord damage in multiple sclerosis: a diffusional kurtosis imaging study
E Raz, M Bester, E E Sigmund, et al.
Acta Neurologica Scandinavica
|
August 9, 2016
Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex<sup>®</sup>
A Carotenuto, R Iodice, M Petracca, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
September 17, 2011
Multiple Sclerosis Severity Scale and whole-brain N-acetylaspartate concentration for patients' assessment
D J Rigotti, A Gass, L Achtnichts, et al.
AJNR. American Journal of Neuroradiology
|
November 27, 2012
Cognitive impairment in mild traumatic brain injury: a longitudinal diffusional kurtosis and perfusion imaging study
E J Grossman, J H Jensen, J S Babb, et al.
AJNR. American Journal of Neuroradiology
|
September 26, 2007
Quantitative assessment of iron accumulation in the deep gray matter of multiple sclerosis by magnetic field correlation imaging
Y Ge, J H Jensen, H Lu, et al.
Neurology
|
April 21, 2012
Two-year serial whole-brain N-acetyl-L-aspartate in patients with relapsing-remitting multiple sclerosis
D J Rigotti, M Inglese, I I Kirov, et al.
European Journal of Neurology
|
August 17, 2019
Preserved brain functional plasticity after upper limb task-oriented rehabilitation in progressive multiple sclerosis
G Boffa, A Tacchino, E Sbragia, et al.
Journal of Endocrinological Investigation
|
February 2, 2012
Vitamin D and parameters of calcium homeostasis in inpatients with and without Type 2 diabetes mellitus
V Carnevale, M Inglese, M A Annese, et al.
Journal of the Neurological Sciences
|
May 27, 2021
Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic?
F Tazza, C Lapucci, M Cellerino, et al.
Page
of 9